网的预测:过去30年有没有改善?
Dominique Clement1,2, Debashis Sarker1,3,4, Aviva Frydman1
1Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Institute of Liver Studies, King's College Hospital, London, UK.
Neuroendocrinology
|June 1, 2025
概括
由于新的治疗方法,神经内分泌瘤 (NETs) 的预后在30年内显著改善. 本综述详细介绍了NET患者不断发展的治疗方法和生存结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 神经内分泌瘤 (NETs) 是一种不常见的新生体,其分类正在演变.
- 研究表明,NET的发病率和流行率正在上升.
- 网络研究的数据来源各不相同,在准确性和偏差方面存在挑战.
研究的目的:
- 审查过去30年神经内分泌瘤 (NET) 预后的变化.
- 为了将预后变化与NET治疗方式的进步相关联.
- 提供NET患者结局的最新概述.
主要方法:
- 1990年至今出版的研究文献综述.
- 对治疗进展的分析,包括索马托斯塔丁类似物,受体放射性核酸疗法,苏尼提尼布,埃弗罗利斯和卡博赞提尼布.
- 检查预后结果,如整体存活率和几十年的无进展存活率.
主要成果:
- 在三十年内观察到神经内分泌瘤 (NET) 预后的显著改善.
- 引入向疗法和全身治疗对患者的生存率产生了积极的影响.
- 研究中的异质性需要仔细解释比较结果.
结论:
- 神经内分泌瘤 (NETs) 患者的预后明显有所改善.
- 治疗策略的进步是改善患者治疗结果的主要驱动因素.
- 持续的研究对于进一步完善NET管理和提高生存率至关重要.
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


